Skip to content
the hub has moved to a new software platform. You will need to login using your email address. Find out more here.

FDA greenlights new Alzheimer's drug amid safety concerns

by Patient-Safety-Learning

· 639 views

The FDA is greenlighting the drug Leqembi after it appeared to slow cognitive decline in some early stage Alzheimer’s patients in spite of some potential risks. In this video, Kristen Dahlgren has more details about findings from the clinical trial.

Watch full story

Source: NBC News, 7 January 2023

    • 0

    User Feedback

    Recommended Comments

    There are no comments to display.

    Create an account or sign in to comment

    Registered address: Patient Safety Learning, China Works SB203, 100 Black Prince Road Vauxhall, London, SE1 7SJ

    Account

    Navigation

    Search

    Search

    Configure browser push notifications
    Chrome (Android)
    1. Tap the lock icon next to the address bar.
    2. Tap Permissions → Notifications.
    3. Adjust your preference.
    Chrome (Desktop)
    1. Click the padlock icon in the address bar.
    2. Select Site settings.
    3. Find Notifications and adjust your preference.